| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT04591951 Family Navigation to Improve ADHD Treatment Adherence for Minority Children |
Trial completed |
| 2026-08-15 | NCT04591951 Family Navigation to Improve ADHD Treatment Adherence for Minority Children |
date change Primary completion pushed: 2026-04-30 -> 2026-07-30 |
| 2026-08-15 | NCT04591951 Family Navigation to Improve ADHD Treatment Adherence for Minority Children |
date change Completion pushed: 2026-04-30 -> 2026-07-30 |
| 2026-08-15 | NCT03948867 Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE) |
overall status: Enrolling by Invitation → Active, Not Recruiting |
| 2026-08-15 | NCT03948867 Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE) |
date change Primary completion moved earlier: 2026-12-31 -> 2022-09-05 |
| 2026-08-11 | NCT04219280 Evaluating Treatment of ADHD in Children With Down Syndrome |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT04219280 Evaluating Treatment of ADHD in Children With Down Syndrome |
date change Primary completion pushed: 2025-09-30 -> 2026-08-31 |
| 2026-08-11 | NCT04219280 Evaluating Treatment of ADHD in Children With Down Syndrome |
date change Completion pushed: 2025-09-30 -> 2026-08-31 |
| 2026-08-07 | NCT03847467 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving… |
Trial completed |
| 2026-08-07 | NCT03847467 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving… |
Enrollment increased: 116 -> 128 participants |
| 2026-08-07 | NCT03847467 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving… |
date change Primary completion moved earlier: 2027-06-30 -> 2026-03-06 |
| 2026-08-07 | NCT03847467 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving… |
date change Completion moved earlier: 2027-06-30 -> 2026-05-28 |
| 2026-08-06 | NCT04216927 NO During CPB in Neonates to Reduce Risk of AKI |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-08-06 | NCT04216927 NO During CPB in Neonates to Reduce Risk of AKI |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-07-31 | NCT04857255 Technology-assisted Language Intervention (TALI) |
Trial completed |
| 2026-07-31 | NCT04857255 Technology-assisted Language Intervention (TALI) |
Enrollment increased: 114 -> 143 participants |
| 2026-07-31 | NCT04857255 Technology-assisted Language Intervention (TALI) |
date change Primary completion moved earlier: 2026-03-31 -> 2025-12-26 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-05 | NCT07748234 Role of Anticoagulation in the Management of Tumor Thrombus | Active, Not Recruiting | |
| 2026-07-22 | NCT07718464 FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05517655 | BEGIN Novel ImagiNG Biomarkers | Cystic Fibrosis | Recruiting |
| NCT07177300 | Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations… | Sickle Cell Anemia (HbSS) | Recruiting |
| NCT04991389 | Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics | Obstructive Sleep Apnea | Recruiting |
| NCT04995562 | Use of Hyperpolarized 129Xe MR Lung Imaging in Infants | Lungs; Developmental Disorder | Recruiting |
| NCT04259970 | Hyperpolarized Imaging for New Treatments | Cystic Fibrosis | Active, Not Recruiting |
| NCT07300956 | Treating Young Children With Attention Deficit Hyperactivity Disorder | Attention-Deficit/Hyperactivity Disorder (ADHD) | Not Yet Recruiting |
| NCT04467957 | Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis | Cystic Fibrosis | Active, Not Recruiting |
| NCT05659147 | Imaging Biomarkers of Pancreatic Function and Disease | Pancreatitis | Enrolling by Invitation |
| NCT04128995 | Surgical or Medical Treatment | Diabetes Mellitus, Type 2 | Active, Not Recruiting |
| NCT04219280 | Evaluating Treatment of ADHD in Children With Down Syndrome | Down Syndrome | Active, Not Recruiting |
| Phase 3 | |||
| NCT07187206 | Safety and Efficacy of FETO in CDH Phase III | Congenital Diaphragmatic Hernia | Recruiting |
| NCT07146048 | A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop | Rheumatic Heart Disease | Recruiting |
| NCT04216927 | NO During CPB in Neonates to Reduce Risk of AKI | AKI | Recruiting |
| Phase 2/3 | |||
| NCT05660746 | Precise Infliximab Exposure and Pharmacodynamic Control | Crohn Disease | Recruiting |
| Phase 2 | |||
| NCT06028113 | A Novel Obesity Prevention Program for High-Risk Infants in Primary Care | Obesity | Recruiting |
| NCT06450925 | Vitamin A Supplementation in Allogeneic Stem Cell Transplantation. | Graft Vs Host Disease | Recruiting |
| NCT06153173 | Mirdametinib in Histiocytic Disorders | Langerhans Cell Histiocytosis (LCH) | Recruiting |
| NCT02143830 | HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy | Fanconi Anemia | Recruiting |
| NCT02532452 | Third Party Viral Specific T-cells (VSTs) | Viral Infection | Recruiting |
| NCT05485155 | Zemaira Eosinophilic Esophagitis Pilot Study | Eosinophilic Esophagitis | Recruiting |
| NCT04230356 | Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific… | Allogeneic Stell Cell Transplant | Recruiting |
| NCT05538208 | The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study | Lupus Nephritis | Recruiting |
| NCT07635056 | Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for… | Neuroblastoma | Recruiting |
| NCT05501756 | Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation | Allogeneic Hematopoietic Cell Transplantation | Recruiting |
| NCT04925375 | Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung… | Interstitial Lung Disease | Recruiting |